Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Lambert

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Hematology (Amsterdam, Netherlands)|May 3, 2012
Beyond patient benefit: clinical development in hemophiliaGünter Auerswald, Silva Zupančić Šalek, Gary Benson, et al.
Blood Transfusion = Trasfusione Del Sangue|June 13, 2014
The European Haemophilia Network (EUHANET)Michael Makris, Gabriele Calizzani, Kathelijn Fischer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 14, 2022
Revised terminal half-life of nonacog alfa as derived from extended sampling data: A real-world study involving 64 haemophilia B patients on nonacog alfa regular prophylaxisBrigitte Tardy, Thierry Lambert, Pierre Chamouni, et al.
European Journal of Haematology|November 10, 2018
Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult-to-treat patientsRolf Ljung, Guenter Auerswald, Gary Benson, et al.
European Journal of Haematology|March 24, 2017
Outcome measures for adult and pediatric hemophilia patients with inhibitorsCedric Hermans, Günter Auerswald, Gary Benson, et al.
Blood Transfusion = Trasfusione Del Sangue|December 18, 2015
Beyond stopping the bleed: short-term episodic prophylaxis with recombinant activated factor FVII in haemophilia patients with inhibitorsSilva Zupančić Šalek, Günter Auerswald, Gary Benson, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 10, 2010
Epidemiological survey of haemophiliacs with inhibitors in France: orthopaedic status, quality of life and cost--the 'Statut Orthopédique des Patients Hémophiles' avec Inhibiteur studyNatalie Stieltjes, Marie F Torchet, Laure Misrahi, et al.
Human Mutation|June 21, 2006
Detection of 95 novel mutations in coagulation factor VIII gene F8 responsible for hemophilia A: results from a single institutionBenoît Guillet, Thierry Lambert, Roseline d'Oiron, et al.
Thrombosis and Haemostasis|September 2, 2016
Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children. Results of a phase 3 trialGili Kenet, Hervé Chambost, Christoph Male, et al.
FEMS Microbiology Letters|May 15, 2002
Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitalsMichèle Saladin, Van Thi Bao Cao, Thierry Lambert, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Hematology (Amsterdam, Netherlands)|May 3, 2012
Beyond patient benefit: clinical development in hemophiliaGünter Auerswald, Silva Zupančić Šalek, Gary Benson, et al.
Blood Transfusion = Trasfusione Del Sangue|June 13, 2014
The European Haemophilia Network (EUHANET)Michael Makris, Gabriele Calizzani, Kathelijn Fischer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 14, 2022
Revised terminal half-life of nonacog alfa as derived from extended sampling data: A real-world study involving 64 haemophilia B patients on nonacog alfa regular prophylaxisBrigitte Tardy, Thierry Lambert, Pierre Chamouni, et al.
European Journal of Haematology|November 10, 2018
Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult-to-treat patientsRolf Ljung, Guenter Auerswald, Gary Benson, et al.
European Journal of Haematology|March 24, 2017
Outcome measures for adult and pediatric hemophilia patients with inhibitorsCedric Hermans, Günter Auerswald, Gary Benson, et al.
Blood Transfusion = Trasfusione Del Sangue|December 18, 2015
Beyond stopping the bleed: short-term episodic prophylaxis with recombinant activated factor FVII in haemophilia patients with inhibitorsSilva Zupančić Šalek, Günter Auerswald, Gary Benson, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 10, 2010
Epidemiological survey of haemophiliacs with inhibitors in France: orthopaedic status, quality of life and cost--the 'Statut Orthopédique des Patients Hémophiles' avec Inhibiteur studyNatalie Stieltjes, Marie F Torchet, Laure Misrahi, et al.
Human Mutation|June 21, 2006
Detection of 95 novel mutations in coagulation factor VIII gene F8 responsible for hemophilia A: results from a single institutionBenoît Guillet, Thierry Lambert, Roseline d'Oiron, et al.
Thrombosis and Haemostasis|September 2, 2016
Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children. Results of a phase 3 trialGili Kenet, Hervé Chambost, Christoph Male, et al.
FEMS Microbiology Letters|May 15, 2002
Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitalsMichèle Saladin, Van Thi Bao Cao, Thierry Lambert, et al.
Pageof 8